Home HOME Neoplasma 2019 Neoplasma Vol.66, No.3, p.427-436, 2019

Journal info

6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal

Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.66, No.3, p.427-436, 2019

Title: MicroRNA-363-3p/p21(Cip1/Waf1) axis is regulated by HIF-2α in mediating stemness of melanoma cells
Author: T. Hao, C. X. Li, X. Y. Ding, X. J. Xing

Abstract: Melanoma is a malignant tumor. The acquisition of stemness by melanoma cells aggravates the malignant transformation, which can be regulated by microRNAs (miRNAs, miR). MiR-363-3p is a key tumor-related miRNA, but its role in stemness and melanoma cells is still unknown. Presently, miR-363-3p induced by hypoxia inducible factor (HIF)-2α has a positive role in melanoma cell stemness. The levels of miR-363-3p and HIF-2α are upregulated in melanoma cell lines. Overexpression of HIF-2α significantly increased levels of miR-363-3p. However, both HIF-2α knockdown and miR-363-3p inhibition decreased the levels of stemness markers (CD133, CD271, Jarid1B and Nanog). Furthermore, the levels of miR-363-3p and HIF-2α were upregulated in fluorescence activated cell sorting (FACS)-sorted CD271high/+ cells. Whereas, miR-363-3p depletion reduced the proportion and the ability of the CD271high/+ cells to form spheroids, decreased the levels of CD133, CD271, Jarid1B and Nanog with restrained proliferative activity of CD271high/+ cells. Additionally, miR-363-3p was confirmed a key downstream effector of HIF-2α. Intriguingly, cyclin-dependent kinase inhibitor 1A [CDKN1A, p21(Cip1/Waf1)], a key inhibitor of S-phase DNA synthesis and cell cycle progression, was confirmed a target gene of miR-363-3p by luciferase reporter gene assay. The protein levels of CD133, CD271, Jarid1B and Nanog were upregulated with enhanced proliferative activity of CD271high/+ cells by inhibition of p21 in melanoma cells. In conclusion, miR-363-3p is induced by HIF-2α to promote stemness of melanoma cells via inhibiting p21. The present study provides novel insights and indicates that HIF-2α/miR-363-3p/p21 signaling may be a potential target in melanoma research and therapy.

Keywords: melanoma cells, stemness, microRNA-363, hypoxia inducible factor (HIF)-2α, p21(Cip1/Waf1)
Published online: 28-May-2019
Year: 2019, Volume: 66, Issue: 3 Page From: 427, Page To: 436

download file

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.